当前位置:首页 - 行情中心 - 宏源药业(301246) - 财务分析

宏源药业

(301246)

  

流通市值:24.56亿  总市值:61.04亿
流通股本:1.61亿   总股本:4.00亿

宏源药业(301246)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.36亿元,每股收益0.09元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益434686.16万元,未分配利润161722.00万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产585665.90万元,负债150979.74万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,322,234,413.75898,125,095.81426,063,8852,054,881,990.91
营业总成本1,265,739,711.39849,871,656.81393,251,587.271,965,280,503.57
营业利润45,679,264.5141,760,234.3935,165,805.81105,644,504.6
利润总额45,366,860.7541,419,361.7435,078,651.5898,558,063.56
净利润36,142,245.3135,809,610.6931,199,061.6287,168,626.24
其他综合收益----
综合收益总额36,142,245.3135,809,610.6931,199,061.6287,168,626.24
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计3,016,003,560.553,047,583,272.493,080,763,286.563,202,265,631.78
非流动资产合计2,840,655,403.122,796,732,514.972,559,499,940.452,448,505,159.56
资产总计5,856,658,963.675,844,315,787.465,640,263,227.015,650,770,791.34
流动负债合计1,178,469,168.741,161,780,264.31875,870,777.75914,828,245.64
非流动负债合计331,328,211.47336,208,342.51371,882,129.89376,105,110.15
负债合计1,509,797,380.211,497,988,606.821,247,752,907.641,290,933,355.79
归属于母公司股东权益合计4,346,861,583.464,346,327,180.644,392,510,319.374,359,837,435.55
股东权益合计4,346,861,583.464,346,327,180.644,392,510,319.374,359,837,435.55
负债和股东权益合计5,856,658,963.675,844,315,787.465,640,263,227.015,650,770,791.34
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计772,338,678.87499,042,012.03162,314,968.391,440,669,124.49
经营活动现金流出小计781,377,883.72517,504,402.07251,812,636.321,405,418,725.75
经营活动产生的现金流量净额-9,039,204.85-18,462,390.04-89,497,667.9335,250,398.74
投资活动现金流入小计3,431,165,537.512,561,109,100.311,346,719,951.553,220,414,364.73
投资活动现金流出小计2,777,121,703.782,141,467,450.831,089,510,810.675,289,640,601.41
投资活动产生的现金流量净额654,043,833.73419,641,649.48257,209,140.88-2,069,226,236.68
筹资活动现金流入小计56,061,209.317,619,723.782,248,928.292,310,110,570.25
筹资活动现金流出小计229,289,250.15140,506,960.925,682,843.93157,020,094.31
筹资活动产生的现金流量净额-173,228,040.84-132,887,237.14-3,433,915.642,153,090,475.94
汇率变动对现金及现金等价物的影响3,173,928.922,993,796.171,290,060.81570,348.75
现金及现金等价物净增加额474,950,516.96271,285,818.47165,567,618.12119,684,986.75
期末现金及现金等价物余额831,355,002.16627,690,303.67521,972,103.32356,404,485.2
TOP↑